Picture of RaQualia Pharma logo

4579 — RaQualia Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Table: RaQualia Pharma -2018 group results

Feb 8 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2018    Dec 31, 2017   Dec 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          744 mln          1.42           2.02                  
               (-47.5 pct)                   (+171.6 pct)              
  Operating     loss 1.08     loss 150 mln      187 mln                
  Recurring     loss 1.06      loss 80 mln      195 mln                
  Net
  Net           loss 1.10      loss 58 mln      153 mln                
  EPS        loss 54.23 yen   loss 2.99 yen    7.52 yen                
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T

Recent news on RaQualia Pharma

See all news